Tulsa Medical Laboratory
About Us
Contact Us
Tulsa Medical Laboratory is pleased to announce that we will offer Cervista™ HTA HPV HR from Hologic™---the makers of the ThinPrep® Pap test starting
March 1, 2010. Cervista™ HTA HPV HR is a highly accurate screening test for 14 high-risk human papillomavirus (HPV) types associated with cervical cancer.

Now you can offer your patients a high-risk HPV screening test that provides new levels of efficiency and responsiveness, including:
  • 99.1% Negative Predictive Value (NPV) for CIN2+
  • No cross-reactivity with common low-risk HPV types

  • An internal control to assess both sample cellularity and contamination
  • Requires only 2ml of specimen, limiting the QNS cases
  • Improved turn-around time
  • HPV 16/18 genotyping for positive Cervista™ HTA HPV HR results
  • Cervista HTA HPV HR Assay - the next generation in HPV DNA testing
Genotyping for HPV types 16 and 18 as an adjunct to Cervista™ HPV HR screening and Pap testing allows for more efficient triage of patients. The Cervista™ HPV HR 16/18 uses the residual extracted DNA from the specimen limiting the Quantity Not Sufficient results.

Tulsa Medical Lab is committed to providing the highest quality tests. If you have any questions, please feel free to call:

    Linda McGraw, Cytology Supervisor, 918-481-7854
    Julie Gregg, Molecular Supervisor, 918-481-7857
Tamara Chaney, MD
Laboratory Director

The new Cellient™ Automated Cell Block System - the first fully-automated cell blocking system built on ThinPrep® technology. Improves capture by maximizing cellularity even from small/scanty samples. Improves presentation by maintaining crisp, clear cellular architectural detail with concentrations of cells within the block.

Allows for review of cytology and cell block simultaneously. Improves consistency by being fully automated with minimal operator dependency. Less cross-contamination risk along with consistently rapid processing time (45 minutes or less).
Hologic Gen-Probe Panther & Cervista HTA - TML acquired the Hologic Cervista HTA (High Throughput Automation) system and the Hologic Gen-Probe Panther. The HTA system is FDA approved and automates the DNA extraction and detection steps of the Hologic Cervista HR HPV test. The HTA provides higher throughput, improved chain of custody and accurate results.

The Hologic Gen-Probe Panther is a fully-automated, random access sampling instrument which is currently FDA approved to perform the Aptima CT/NG test and the new Trichomonas vaginalis nucleic acid amplification test.

A single one milliliter aliquot from a patient's Thin Prep Pap Test vial can be tested for up to three different assays simultaneously on the Panther.

FDA approval is currently pending for the Aptima HPV test. A genotyping assay for HPV 16, 18, 45 and HSV-1 and HSV-2 assays are currently in development.
Ask us about our new, easy to use, Encompass Web-Based reporting system. Clinicians and their office staff can now access our web-based reporting system to check on report status and printing options for both Cytology and Tissue reports. No special equipment needed - just access to the internet.

For more information or to have your computer workstations set up for Encompass, please contact Tanya Odle at Tulsa Medical Laboratory, 918.712.5571.
©2013 Tulsa Medical Lab. All rights reserved. 6565 S. Yale Ave. Ste. 410 Tulsa, OK 74136 Phone: 918.481.7844 Fax: 918.481.7852